Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
07/2007
07/24/2007US7247463 Enzymes with lipase/acyltransferase activity, nucleic acids encoding the same and methods of use thereof
07/24/2007US7247454 Methods for recombinant peptide production
07/24/2007US7247443 Sensor constructs and detection methods
07/24/2007US7247331 Isolating milk proteins by passing milk or whey over a cation-exchange resin, eluting the fraction retained by an aqueous salted solution and desalting and sterilizing the eluate; pharmaceutical and food compositions
07/24/2007CA2121798C Novel cytokine
07/24/2007CA1341536C Transforming growth factor peptides
07/24/2007CA1341535C Transforming growth factor peptides
07/19/2007WO2007081387A1 Microfluidic devices, methods of use, and kits for performing diagnostics
07/19/2007WO2007081385A2 Microfluidic devices and methods of use in the formation and control of nanoreactors
07/19/2007WO2007081067A1 A method of separating a peptidoglycan recognition protein from a hemolymph of tenebrio molitor larvae
07/19/2007WO2007080197A2 Immobilised enzymes
07/19/2007US20070169211 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
07/19/2007US20070167609 Nanoscale array biomolecular bond enhancer device
07/19/2007US20070166352 polyglycolic acid or polylactic acid or glycolic acid-lactic acid copolymer as biocompatible polymer having dispersed therein an active agent such as exendin-4; antidiabetic agent
07/19/2007US20070163882 Capillary electrophoresis apparatus and electrophoresis method
07/19/2007CA2636855A1 Microfluidic devices and methods of use in the formation and control of nanoreactors
07/19/2007CA2636194A1 A method of separating a peptidoglycan recognition protein from a hemolymph of tenebrio molitor larvae
07/18/2007EP1808438A2 Purification and stabilization of peptide and proteins in pharmaceutical agents
07/18/2007EP1807525A2 Diacylglycerol acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms
07/18/2007EP1807467A1 Processes for preparing glatiramer
07/18/2007EP1807442A1 S-alkyl-sulphenyl protection groups in solid-phase synthesis
07/18/2007EP1807205A1 A method of antibody purification
07/18/2007EP1807101A2 Devices and methods for integrated continuous manufacturing of biological molecules
07/18/2007EP1446442B1 Complexating systems, intermediates for their production and method for obtaining and using the same
07/18/2007EP1284987B1 Methods for refolding proteins containing free cysteine residues
07/18/2007CN1326869C Method for tissue culturing ice edge plant in high mountains and for production of excreting protein-from cold induction
07/18/2007CN1326868C Decarboxamidation grain protein-chrominium element chelate and preparation method
07/18/2007CN101001866A Modified human interferon polypeptides and their uses
07/18/2007CN100999545A Process of recovering sericine by ion exchanging
07/18/2007CN100999544A Process of acquiring antibiosis activity of conarachine II
07/18/2007CN100999543A Production tech. of separating protein from special soybean
07/17/2007US7244837 Comprises nucleotide sequences coding octopamine/tyramine transporter proteins for use identifying modulator which inhibit moth propagation; biological pest control; insecticides
07/17/2007US7244827 Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
07/17/2007US7244825 Vial containing a dried native Factor VIII composition containing trehalose as a stabilizer and no albumin; may be reconstituted with water or brine for administration to a hemophilic patient by injection; stable at up to 60 degrees C.
07/17/2007US7244824 Blood-coagulation factor VIII (or antihemophilic factor) containing trehalose stabilizer in absence of albumin; reconstitution with water
07/17/2007US7244821 Expression vector comprising nucleotide sequences coding glucose transport protein 4 ( GLUT4) for identifying modulator for prevention and treatment of diabetes
07/17/2007US7244815 Attachment and elaboration strategies for inverse peptide synthesis
07/17/2007US7244708 Inhibitors of memapsin 2 and use thereof
07/17/2007US7244589 Chimeric immunogens
07/17/2007US7244588 Cold-induced expression vector
07/17/2007US7244428 PRO1357 antibodies
07/17/2007CA2216167C Glycopeptide antibiotic derivatives
07/17/2007CA2134087C Copolymers and non-porous, semi-permeable membrane thereof and its use for permeating molecules of predetermined molecular weight range
07/12/2007WO2007079458A2 Protein hydrolysates and method of making
07/12/2007WO2007078868A1 Massively parallel synthesis of biopolymeric arrays
07/12/2007WO2007077365A2 IMMUNOGLOBULIN G (IgG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES AND OF POLYREACTIVE IgGs
07/12/2007WO2007077112A1 Methods for the synthesis of arginine-containing peptides
07/12/2007WO2007076993A1 Process for forming disulphide bridges
07/12/2007WO2007063129A3 Insolation of peptides , polypeptides and proteins
07/12/2007WO2007028025A3 Methods and compositions for the treatment and prevention of cholera
07/12/2007WO2007025221A3 Protein structure determination
07/12/2007US20070161785 High density metal ion affinity compositions and methods for making and using the same
07/12/2007US20070161784 Methods and products of amino acid isolation
07/12/2007US20070161116 Differential analysis of cell surface proteins on closed membrane structures by labelling with dyes in the presence of an internal standard
07/12/2007US20070161014 Nucleic acid binding proteins
07/12/2007US20070160612 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
07/12/2007US20070160534 Conjugate comprising a peptide having an engineered amino acid sequence capable of binding a plasma protein, said peptide conjugated to the therapeutic or diagnostic substance, wherein elimination half time of conjugate exceeds that of unconjugated therapeutic or diagnostic substance; peptide ligands
07/12/2007US20070160025 Method for allocating reverse traffic channels at the time of handoff in a cdma communication system
07/12/2007US20070158192 Apparatus and method for coupling microfluidic systems with a mass spectrometer utilizing rapid voltage switching
07/12/2007DE4208258B4 Verfahren zur Herstellung von kristallinem Ciclosporin in kugelartiger Teilchenform und seine Verwendung, insbesondere zur pulmonalen Verabreichung A process for producing crystalline Ciclosporin in spheroidal particulate form and to its use, in particular for pulmonary administration
07/12/2007DE10361243B4 Untersuchungsverfahren zur Phagozytose Investigation process of phagocytosis
07/12/2007DE10121201B4 Photoaktivierbare Polysaccharidderivate für die Immobilisierung von Biomolekülen Photoactivatable polysaccharide derivatives for the immobilization of biomolecules
07/12/2007CA2635889A1 Drug-polymer conjugates
07/12/2007CA2634997A1 Immunoglobulin g (igg) concentrate depleted of anti-a and anti-b antibodies and of polyreactive iggs
07/11/2007EP1806586A1 Mass labels
07/11/2007EP1805514A2 Immunoassays for topiramate
07/11/2007EP1805320A2 Methods for refolding of recombinant antibodies
07/11/2007EP1805205A1 Methods for refolding polypeptides
07/11/2007EP1805204A2 Process for production of bivalirudin
07/11/2007EP1805203A2 On-resin peptide cyclization
07/11/2007EP1781706A4 New chiral columns with broad chiral selectivity
07/11/2007EP1700114A4 Method for enrichment/separation of protein or peptide
07/11/2007EP1631597A4 Displaceable linker solid phase chemical ligation
07/11/2007EP1624950B1 Process for prefiltration of a protein solution
07/11/2007EP1179184B1 Identifying material from a breast duct
07/11/2007EP0577752B2 Human pf4a receptors and their use
07/11/2007CN1997739A Method of disulfide crosslink forming type in vitro protein synthesis
07/11/2007CN1997694A Methods for the production of polymer carrier materials based on carbon hydrate-bis-(meth)acryl- amides
07/11/2007CN1997671A Peptide purification by means of hard metal ion affinity chromatography
07/11/2007CN1997666A Polyethylene glycol modified interferon compositions and methods of use thereof
07/11/2007CN1997277A Methods for treating cancer using vascular endothelial cell growth inhibitor VEGI-192A
07/11/2007CN1995958A Bioactive substance automatic extracting device
07/11/2007CN1995371A Embryo cell active protein preparation method and its uses in skin care product
07/11/2007CN1995062A Preparation method of wheat bran antifreeze protein
07/11/2007CN1325516C Biomimetic affinity purification method of vitellus immune globulin
07/11/2007CN1325514C Scorpion pain-stopping anti-tumor Val-Arg-Gly peptide and its preparation method
07/11/2007CN1325513C Oil bodies and associated proteins as affinity matrices
07/11/2007CN1325511C Glutathion purification and separation method
07/10/2007US7241883 Functionalized compositions for improved immobilization
07/10/2007US7241874 Purifying bone morphogenic protein from demineralized bone tissue; implantable devices for bone and tendon repair and/or regeneration
07/10/2007US7241871 Method and process for the production of collagen preparations from invertebrate marine animals and compositions thereof
07/10/2007US7241869 Modified polypeptides stabilized in a desired conformation and methods for producing same
07/10/2007US7241866 Using amines or amino acids as mobile phase modifiers in chromatography
07/10/2007US7241744 Delivering into cells of the subject an effective amount of a nucleic acid expression construct that encodes a growth-hormone-releasing-hormone ("GHRH") or functional biological equivalent thereof for therapy of anemia
07/10/2007US7241603 Fibrinogen and fibronectin-containing starting solution is treated with precipitating composition comprising two components that modify solubility of fibrinogen and/or fibronectin; precipitate is formed in single-step; skin
07/10/2007US7241585 For diagnosis of cancer, immunological disorders, viral disorders, and apoptotic disorders; kits; drug screening
07/10/2007US7241580 Immunoaffinity chromatography using epitope tags to polyol-responsive monoclonal antibodies
07/10/2007US7241574 Preparing DNA binding protein comprising multiple zinc finger domains for use in identifying modulators of protein-nucleic acid recognition; gene expression inhibition
07/10/2007US7241573 Genetically engineered protein comprising multiple zinc finger domains for use as regulatory quadruplets in gene expression analysis
07/10/2007US7241419 Circuits for the control of output current in an electronic device for performing active biological operations